| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
LY 56110 manufacturers
- LY 56110
-
- $1520.00
-
2025-08-22
- CAS:26766-37-0
- Purity:
- Supply Ability: 10g
|
| | LY 56110 Basic information |
| Product Name: | LY 56110 | | Synonyms: | LY 56110;Pyrimidine, 5-[bis(4-chlorophenyl)methyl]- | | CAS: | 26766-37-0 | | MF: | C17H12Cl2N2 | | MW: | 315.2 | | EINECS: | | | Product Categories: | | | Mol File: | 26766-37-0.mol |  |
| | LY 56110 Chemical Properties |
| Boiling point | 438.3±40.0 °C(Predicted) | | density | 1.296±0.06 g/cm3(Predicted) | | pka | 1.75±0.10(Predicted) |
| | LY 56110 Usage And Synthesis |
| Description | LY 56110 is a novel class of nonsteroidal aromatase inhibitor. | | Uses | LY56110 is an orally active aromatase inhibitor. LY56110 inhibits P-450-dependent p-nitroanisole O-demethylation and ethylmorphine N-demethylation in hepatic microsomes isolated from rat, with the IC50 of 2.5 and 11 μΜ, respectively. LY56110 can be used for neurological disorder study[1][2]. | | References | [1] Lindstrom TD, et al. Disposition of the aromatase inhibitor LY56110 and associated induction and inhibition studies in rats, dogs, and monkeys. Fundam Appl Toxicol. 1987;8(4):595-604. DOI:10.1016/0272-0590(87)90144-8
[2] O'Neill LA, et al. Effect of estrogen inhibitors on conceptus estrogen synthesis and development in the gilt. Domest Anim Endocrinol. 1991;8(1):139-153. DOI:10.1016/0739-7240(91)90048-o |
| | LY 56110 Preparation Products And Raw materials |
|